Heron Therapeutics reported $-63888000 in Pre-Tax Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Alnylam Pharmaceuticals ALNY:US $ -274.67M 35.32M
Amarin AMRN:US $ -64.8M 36.45M
Anika Therapeutics ANIK:US $ -3.28M 0.42M
Arrowhead Research ARWR:US $ -72.05M 116.41M
Eisai 4523:JP Y 9722M 30501M
Esperion Therapeutics ESPR:US $ -66324000 9.59M
Immunogen IMGN:US $ -62.02M 37.88M
Insmed INSM:US $ -95144000 908K
Nektar Therapeutics NKTR:US $ -158.97M 68.7M
Neurocrine Biosciences NBIX:US $ -23.3M 44.7M
Sangamo Biosciences SGMO:US $ -43.09M 0.83M
Ultragenyx Pharmaceutical RARE:US $ -157.86M 6.1M
Veracyte VCYT:US $ -9.65M 4.82M